Shareholder rights

Search documents
REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Replimune Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-08 22:24
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Replimune (REPL) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Replimune between November 22, 2024 and July 21, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally r ...
IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-08 19:05
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Iovance (IOVA) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Iovance between May 9, 2024 and May 8, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized sh ...
CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-08 18:16
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Capricor (CAPR) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Capricor between October 9, 2024 and July 10, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recog ...
FIVE BELOW ALERT: Bragar Eagel & Squire, P.C. is Investigating Five Below, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-08 17:15
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Five Below (FIVE) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Five Below between March 20, 2024 to July 16, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally rec ...
Wells Fargo Under Investigation: A Closer Look at Shareholder Rights and Stock Performance
Financial Modeling Prep· 2025-10-03 22:00
Core Viewpoint - Wells Fargo is facing scrutiny over its hiring practices and potential breaches of fiduciary duties, yet it maintains a strong market position and positive investor outlook despite past controversies [1][6]. Group 1: Legal Investigations - Bragar Eagel & Squire, P.C. is investigating potential claims against Wells Fargo for breaches of fiduciary duties related to a class action complaint filed on June 28, 2022 [1][6]. - The investigation focuses on the period from February 24, 2021, to June 9, 2022, concerning the actions of Wells Fargo's board [1]. Group 2: Hiring Practices Controversy - Wells Fargo introduced a "Diverse Search Requirement" in 2020, mandating that at least 50% of interview candidates for certain roles be from underrepresented groups [2]. - Allegations surfaced regarding fake interviews, leading to a 1.04% drop in stock price, closing at $41.67 on May 20, 2022 [2]. - Following further scrutiny, Wells Fargo paused its diverse slate hiring policy, and a federal criminal inquiry was reported, resulting in an 8.62% decline in stock price, closing at $38.99 on June 13, 2022 [3]. Group 3: Market Performance and Analyst Ratings - Evercore ISI maintained an "Outperform" rating for Wells Fargo as of September 30, 2025, with the stock priced at $84.65 and raised the price target from $94 to $98 [4]. - Currently, Wells Fargo's stock is priced at $80.94, reflecting a slight increase of 0.54% today, with trading fluctuations between $80.44 and $81.69 [4]. - The company's market capitalization is approximately $259.27 billion, with a trading volume of 5,162,424 shares, indicating strong investor confidence despite past controversies [5].
COMPASS (CODI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Compass Diversified and Encourages Investors to Inquire About Their Rights
Globenewswire· 2025-10-02 11:47
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Compass (CODI) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Compass between May 1, 2024, to May 7, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recogniz ...
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-02 11:42
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648 NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C. ...
KYVERNA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-02 11:17
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) on behalf of long-term stockholders following a class action complaint that was filed against Kyverna on December 9, 2024 with a Class Period pursuant and/or traceable to the Company’s offering documents issued in connection with its initial public offering (“IPO”) conducted on Febr ...
MATCH GROUP INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Match Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-02 11:13
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Match Group, Inc. (NASDAQ: MTCH) on behalf of long-term stockholders following a class action complaint that was filed against Match Group on November 13, 2024 with a Class Period from May 2, 2023 to November 6, 2024. Our investigation concerns whether the board of directors of Match Group have breached their fiduciary duti ...
ADM INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Archer-Daniels-Midland Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-02 11:13
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Archer-Daniels-Midland Company (NYSE: ADM) on behalf of long-term stockholders following a class action complaint that was filed against ADM on January 24, 2024 with a Class Period from April 30, 2020 through January 22, 2024. Our investigation concerns whether the board of directors of ADM have breached their fiduciary dut ...